What is Larifan?

An original active substance – Larifan was developed at the Latvian Academy of Sciences and at present is produced at Larifans Ltd. Larifan is a double-stranded RNA (dsRNA) of natural origin obtained from bacteriophage-infected E.coli cells. Larifan has been developed as a new poly-functional and wide-spectrum medical drug for viral and oncologic diseases.

Larifan possesses multiple biological activities like interferon-inducing, immunomodulating, antiviral, antitumoral and antimutagenic properties.

Drug and cosmetic forms and consumer goods of Larifan are registered in different European and Asian coutries


Why Larifan?


Larifan antivirus spectrum is very extensive, the active substance of Larifan attacks any virus

Dr. Guna Feldmane

Creator of Larifan

Where are we located?

has been added to the cart. View Cart